Clinical trial · Observational
Spontaneous Regression in Metastatic Melanoma and Renal Cell Carcinoma
Blood Drawing for Study of Peripheral Blood T-lymphocytes and Other Parameters in Patients With Metastatic Melanoma and Renal Cell Cancer With Spontaneous Regression
NCT03728842CI-TRIAL-00096807active not recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
The purpose of this study is to collect blood and clinical data from patients with metastatic melanoma and renal cell cancer who have experienced spontaneous regression for studies of immune response and other factors that may influence these occurrences.
Conditions
Conditions (1)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Melanoma; Renal Cell Carcinoma | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Blood collection for laboratory studies | Other | — | UNRESOLVED |
| Data collection from medical record | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- Spontaneous regression
- description
- Patients must have metastatic melanoma or renal cell cancer with spontaneous regression.
- interventionNames
- Other: Blood collection for laboratory studies
- Other: Data collection from medical record
Primary outcomes (1)
- measure
- Number of blood samples collected
- timeFrame
- 1 year
- description
- samples collected from metastatic melanoma and renal cell cancer patients
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
Show eligibility criteria text
Inclusion Criteria 1. ≥ 18 years old at the time of informed consent 2. Ability to provide written informed consent and HIPAA authorization 3. Patients must have metastatic melanoma or renal cell cancer with spontaneous regression. 4. Willingness to undergo phlebotomy for research blood samples Exclusion Criteria 1. Concurrent disease or condition that would make the patient inappropriate for study participation or any serious medical or psychiatric disorder that would interfere with the subject's safety 2. Dementia, altered mental status, or any psychiatric condition that would prohibit the understanding or rendering of informed consent
References
Publications (0)
Data not yet available
No reference posted for this study.